GlassScriptPhysician profile
Saurabh Talathi
NPI 1649675125
$317.50
in general payments reported to CMS, 2019-2025
7 companies · $39.79 in 2025
The $39.79 reported for 2025 was less than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $150 · 2023: $18.21 · 2024: $110 · 2025: $39.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $167.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $168.21 | 2022-2023 | Gattex |
| Qol Medical, LLC | $49.34 | 2024 | Sucraid |
| Rhythm Pharmaceuticals, INC. | $23.65 | 2025 | Imcivree |
| Avanos Medical | $22.20 | 2024 | Mic-Key |
| Genzyme Corporation | $21.57 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $16.39 | 2024 | Bylvay |
| Aimmune Therapeutics, INC. | $16.14 | 2025 | Zenpep |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saurabh Talathi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.